Development and validation of a N6 methylation regulator-related gene signature for prognostic and immune response prediction in non-small cell lung cancer: Am J Cancer Res. 2023; 13(7): 2984-2997
American Journal of Cancer Research · 2026 · 16 (10) · 4676-4678
DOI: 10.62347/inyp5017 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Cancer Research, 2026. Verfasst von Xiang Li und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Li, X., Ma, J., Sun, Z., Li, N., Jiao, G., Zhang, T., & Cao, H. (2026). Development and validation of a N6 methylation regulator-related gene signature for prognostic and immune response prediction in non-small cell lung cancer: Am J Cancer Res. 2023; 13(7): 2984-2997. American Journal of Cancer Research, 16(10), 4676-4678. https://doi.org/10.62347/inyp5017
Vancouver
Li X, Ma J, Sun Z, Li N, Jiao G, Zhang T, et al. Development and validation of a N6 methylation regulator-related gene signature for prognostic and immune response prediction in non-small cell lung cancer: Am J Cancer Res. 2023; 13(7): 2984-2997. American Journal of Cancer Research. 2026;16(10):4676-4678. doi:10.62347/inyp5017
BibTeX
@article{Li2026,
author = {Li, Xiang and Ma, Jinlong and Sun, Zhenqian and Li, Na and Jiao, Guangjun and Zhang, Tianqi and Cao, Hongxin},
title = {Development and validation of a N6 methylation regulator-related gene signature for prognostic and immune response prediction in non-small cell lung cancer: Am J Cancer Res. 2023; 13(7): 2984-2997},
journal = {American Journal of Cancer Research},
year = {2026},
volume = {16},
number = {10},
pages = {4676--4678},
doi = {10.62347/inyp5017}
}
EUVIMED